LIV-1 Antibody-Drug Conjugate: A Novel Therapeutic Agent for Breast Cancer

被引：0
|
作者：
Smith, L. M. [1 ]
Sussman, D. [1 ]
Nesterova, A. [1 ]
Westendorf, L. [1 ]
Duniho, S. [1 ]
Anderson, M. [1 ]
Mbow, B. [1 ]
Gregoire, A. [1 ]
Hunter, J. [1 ]
Whiting, N. [1 ]
Law, C. L. [1 ]
Benjamin, D. R. [1 ]
机构：
[1] Seattle Genet Inc, Bothell, WA USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P6-15-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-15-16
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Trastuzumab-DM1: A Clinical Update of the Novel Antibody-Drug Conjugate for HER2-Overexpressing Breast Cancer
    Barginear, Myra F.
    John, Veena
    Budman, Daniel R.
    MOLECULAR MEDICINE, 2012, 18 (11) : 1473 - 1479
  • [42] Sequencing Antibody-Drug Conjugate after Antibody-Drug Conjugate in Metastatic Breast Cancer (A3 study): Multi-Institution Experience and Biomarker Analysis
    Abelman, Rachel Occhiogrosso
    Spring, Laura
    Fell, Geoffrey
    Davis, Andrew
    Hensing, Whitney
    Ryan, Phoebe
    Vidula, Neelima
    Wander, Seth
    Medford, Arielle
    Shin, Jennifer
    Abraham, Elizabeth
    Isakoff, Steven
    Moy, Beverly
    Ellisen, Leif
    Bardia, Aditya
    CANCER RESEARCH, 2024, 84 (09)
  • [43] Sequencing Antibody-Drug Conjugate After Antibody-Drug Conjugate in Metastatic Breast Cancer (A3 Study): Multi-institution Experience and Biomarker Analysis
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2024, 22 (01)
  • [44] A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
    Jin, Yangbing
    Zhang, Zehui
    Zou, Siyi
    Li, Fanlu
    Chen, Hao
    Peng, Chenghong
    Deng, Xiaxing
    Wen, Chenlei
    Shen, Baiyong
    Zhan, Qian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] CNTN4 as a novel target for solid cancer with antibody-drug conjugate
    Cha, Mi Young
    Kim, Hyunuk
    Byun, Seungmin
    Ha, Youngeun
    Park, Kitae
    Yu, Hyunkyung
    Jeon, Bu-Nam
    Kim, Mira
    Moon, Soojung
    Park, Kyung Mi
    Park, Hansoo
    CANCER RESEARCH, 2024, 84 (06)
  • [46] Development of CDCP1-targeting antibody-drug conjugate for Triple negative and metastatic breast cancer
    Gough, Madeline
    Khan, Tashbib
    Kwah, Kayden
    He, Yaowu
    Ratnayake, Gishan
    Pyke, Christopher
    Snell, Cameron
    Hooper, John
    Kryza, Thomas
    CANCER RESEARCH, 2023, 83 (05)
  • [47] Antibody-Drug Conjugate Targets
    Teicher, B. A.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 982 - 1004
  • [48] An Immunosuppressive Antibody-Drug Conjugate
    Wang, Rongsheng E.
    Liu, Tao
    Wang, Ying
    Cao, Yu
    Du, Jintang
    Luo, Xiaozhou
    Deshmukh, Vishal
    Kim, Chan Hyuk
    Lawson, Brian R.
    Tremblay, Matthew S.
    Young, Travis S.
    Kazane, Stephanie A.
    Wang, Feng
    Schultz, Peter G.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (09) : 3229 - 3232
  • [49] The antibody-drug conjugate landscape
    Flynn, Patrick
    Suryaprakash, Smruthi
    Grossman, Dan
    Panier, Val
    Wu, John
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 577 - 578
  • [50] A distinct role in breast cancer for two LIV-1 family zinc transporters
    Taylor, Kathryn M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2008, 36 : 1247 - 1251
12345